PKD2 and autosomal dominant polycystic kidney disease: Accumulating evidence indicates that these genes represent the most powerful determinant of disease severity in patients with ADPKD; survival to ESRD is 15–20 years less in patients with PKD1, than in those with PKD2 mutations [8, 11].